Bristol-Myers Squibb Company BMY will host a teleconference on Sunday, October 9, 2016, at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark. Company executives will provide an overview of data presented at the meeting, with a focus on the company's Immuno-Oncology portfolio, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: investor.bms.com, by dialing toll free (877) 258-2708 or international (647) 252-4456, confirmation code: 74677318. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 4:30 p.m. EDT on October 9, 2016 through 11:59 p.m. EDT on October 16. The replay can be accessed at investor.bms.com or by dialing (855) 859-2056 or (404) 537-3406, confirmation code: 74677318.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006577/en/
Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251, ken.dominski@bms.com
or
Investors:
Tim
Power, 609-252-7509, timothy.power@bms.com
Bill
Szablewski, 609-252-5894, william.szablewski@bms.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.